NARI logo

Inari Medical (NARI) Company Overview

Profile

Full Name:

Inari Medical, Inc.

Sector:

Healthcare

Country:

United States

IPO:

May 22, 2020

Indexes:

Not included

Description:

Inari Medical is a company that manufactures specialized medical equipment for minimally invasive treatment of patients suffering from venous diseases. It was founded in 2011 and is headquartered in Irvine, California. The company began its direct commercial activities in 2017 after the approval by the US Food and Drug Administration (FDA) of its first two devices: - ClotTriever for the treatment of deep vein thrombosis. - FlowTriever for the treatment of pulmonary embolism and clots in the right atrium.

Key Details

Price

$79.85

Annual Revenue

$493.63 M(+28.73% YoY)

Annual EPS

-$0.03(+94.55% YoY)

Beta

0.26

Events Calendar

Earnings

Next earnings date:

Feb 28, 2025

Recent quarterly earnings:

Oct 28, 2024

Recent annual earnings:

Feb 28, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 8, 25 BTIG
Neutral
Jan 7, 25 William Blair
Market Perform
Jan 7, 25 Wells Fargo
Equal-Weight
Jan 7, 25 Piper Sandler
Neutral
Jan 7, 25 Canaccord Genuity
Hold
Jan 7, 25 Baird
Neutral
Dec 18, 24 Truist Securities
Hold
Dec 17, 24 Oppenheimer
Outperform
Oct 30, 24 Needham
Hold
Oct 29, 24 Truist Securities
Hold

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Stockholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Stockholders to Inquire about Securities Investigation
NARI
accessnewswire.comFebruary 5, 2025

NEW YORK CITY, NY / ACCESS Newswire / February 5, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI). Investors who purchased Inari securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NARI.

Reasons to Retain Inari Medical Stock in Your Portfolio for Now
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
Reasons to Retain Inari Medical Stock in Your Portfolio for Now
NARI
zacks.comFebruary 5, 2025

NARI continues to gain from its expanded product portfolio. The company's expansion in China and Japan bodes well.

Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
NARI
accessnewswire.comFebruary 2, 2025

NEW YORK CITY, NY / ACCESS Newswire / February 2, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI). Investors who purchased Inari securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NARI.

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Inari Medical, Inc. (NARI) And Encourages Shareholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Inari Medical, Inc. (NARI) And Encourages Shareholders to Reach Out
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Inari Medical, Inc. (NARI) And Encourages Shareholders to Reach Out
NARI
accessnewswire.comJanuary 26, 2025

NEW YORK CITY, NY / ACCESS Newswire / January 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI). Investors who purchased Inari securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NARI.

Why Is Inari Medical, Inc. (NARI) Among the Hottest Mid-Cap Stocks So Far in 2025?
Why Is Inari Medical, Inc. (NARI) Among the Hottest Mid-Cap Stocks So Far in 2025?
Why Is Inari Medical, Inc. (NARI) Among the Hottest Mid-Cap Stocks So Far in 2025?
NARI
Insider MonkeyJanuary 19, 2025

We have just put together a list of the 10 most popular mid-cap stocks of 2025. In this article, we will examine how Inari Medical, Inc. (NASDAQ:NARI) compares to other mid-cap stocks. If you have been focused on the well-known companies in the S&P 500, you may be overlooking some interesting options.

Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Inari Medical, Inc. (NARI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
NARI
accessnewswire.comJanuary 19, 2025

NEW YORK CITY, NY / ACCESS Newswire / January 19, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI). Investors who purchased Inari securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NARI.

Are You Looking for a Top Momentum Pick? Why Inari Medical, Inc. (NARI) is a Great Choice
Are You Looking for a Top Momentum Pick? Why Inari Medical, Inc. (NARI) is a Great Choice
Are You Looking for a Top Momentum Pick? Why Inari Medical, Inc. (NARI) is a Great Choice
NARI
zacks.comJanuary 16, 2025

Does Inari Medical, Inc. (NARI) have what it takes to be a top stock pick for momentum investors? Let's find out.

Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Shareholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Shareholders to Inquire about Securities Investigation
Bronstein, Gewirtz & Grossman, LLC Encourages Inari Medical, Inc. (NARI) Shareholders to Inquire about Securities Investigation
NARI
accesswire.comJanuary 15, 2025

NEW YORK CITY, NY / ACCESSWIRE / January 15, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Inari Medical, Inc. ("Inari" or "the Company") (NASDAQ:NARI). Investors who purchased Inari securities prior to March 10, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/NARI.

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Inari Medical, Inc. - NARI
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Inari Medical, Inc. - NARI
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Inari Medical, Inc. - NARI
NARI
prnewswire.comJanuary 7, 2025

NEW YORK , Jan. 7, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Inari Medical, Inc. (Nasdaq: NARI ), relating to the proposed merger with Stryker.

Medical Stock Surges to Multi-Year Highs on Acquisition News
Medical Stock Surges to Multi-Year Highs on Acquisition News
Medical Stock Surges to Multi-Year Highs on Acquisition News
NARI
schaeffersresearch.comJanuary 7, 2025

Shares of Inari Medical Inc (NASDAQ:NARI) are 21.5% higher in premarket trading, on track to open at nearly $79 amid news that Stryker (SYK) agreed to acquire the medical device maker in an all-cash deal worth roughly $4.9 billion, or $80 per share.

FAQ

  • What is the ticker symbol for Inari Medical?
  • Does Inari Medical pay dividends?
  • What sector is Inari Medical in?
  • What industry is Inari Medical in?
  • What country is Inari Medical based in?
  • When did Inari Medical go public?
  • Is Inari Medical in the S&P 500?
  • Is Inari Medical in the NASDAQ 100?
  • Is Inari Medical in the Dow Jones?
  • When was Inari Medical's last earnings report?
  • When does Inari Medical report earnings?
  • Should I buy Inari Medical stock now?

What is the ticker symbol for Inari Medical?

The ticker symbol for Inari Medical is NASDAQ:NARI

Does Inari Medical pay dividends?

No, Inari Medical does not pay dividends

What sector is Inari Medical in?

Inari Medical is in the Healthcare sector

What industry is Inari Medical in?

Inari Medical is in the Medical Devices industry

What country is Inari Medical based in?

Inari Medical is headquartered in United States

When did Inari Medical go public?

Inari Medical's initial public offering (IPO) was on May 22, 2020

Is Inari Medical in the S&P 500?

No, Inari Medical is not included in the S&P 500 index

Is Inari Medical in the NASDAQ 100?

No, Inari Medical is not included in the NASDAQ 100 index

Is Inari Medical in the Dow Jones?

No, Inari Medical is not included in the Dow Jones index

When was Inari Medical's last earnings report?

Inari Medical's most recent earnings report was on Oct 28, 2024

When does Inari Medical report earnings?

The next expected earnings date for Inari Medical is Feb 28, 2025

Should I buy Inari Medical stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions